MorphoSys Strengthens Patent Position on anti-CD38 Cancer Program MOR202

News   Dec 06, 2012

 
MorphoSys Strengthens Patent Position on anti-CD38 Cancer Program MOR202
 
 
 
FURTHER INFORMATION
 

Like what you just read? You can find similar content on the communities below.

Cancer Research Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 
 

Comments | 0 ADD COMMENT